These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 36384376)
1. Fluoroquinolones: old drugs, putative new toxicities. Bove C; Baldock RA; Champigneulle O; Martin L; Bennett CL Expert Opin Drug Saf; 2022 Nov; 21(11):1365-1378. PubMed ID: 36384376 [TBL] [Abstract][Full Text] [Related]
2. An evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin-association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the Food and Drug Administration and the European Medicines Agency. Bennett AC; Bennett CL; Witherspoon BJ; Knopf KB Expert Opin Drug Saf; 2019 Nov; 18(11):1055-1063. PubMed ID: 31500468 [No Abstract] [Full Text] [Related]
3. Fluoroquinolone-related neuropsychiatric and mitochondrial toxicity: a collaborative investigation by scientists and members of a social network. Kaur K; Fayad R; Saxena A; Frizzell N; Chanda A; Das S; Chatterjee S; Hegde S; Baliga MS; Ponemone V; Rorro M; Greene J; Elraheb Y; Redd AJ; Bian J; Restaino J; Norris LB; Qureshi ZP; Love BL; Brookstaver B; Georgantopoulos P; Sartor O; Raisch DW; Rao G; Lu K; Ray P; Hrusheshky W; Schulz R; Ablin R; Noxon V; Bennett CL; J Community Support Oncol; 2016 Feb; 14(2):54-65. PubMed ID: 26955658 [TBL] [Abstract][Full Text] [Related]
4. Current progress of fluoroquinolones-increased risk of aortic aneurysm and dissection. Jun C; Fang B BMC Cardiovasc Disord; 2021 Sep; 21(1):470. PubMed ID: 34583637 [TBL] [Abstract][Full Text] [Related]
5. Impact of the US Food and Drug Administration warning regarding increased risk of aortic aneurysms or aortic dissections on fluoroquinolone prescribing trends. Rizk JG; Slejko JF; Heil EL; Seo D; Qato DM BMJ Open Qual; 2024 Jul; 13(3):. PubMed ID: 39053916 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of FDA Boxed Warning on Prescribing Patterns of Fluoroquinolones for Uncomplicated Urinary Tract Infections. Cowart K; Worley M; Rouby NE; Sando K Ann Pharmacother; 2019 Dec; 53(12):1192-1199. PubMed ID: 31319681 [No Abstract] [Full Text] [Related]
7. Outpatient fluoroquinolone prescribing patterns before and after US FDA boxed warning. Bratsman A; Mathias K; Laubscher R; Grigoryan L; Rose S Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):701-707. PubMed ID: 32390266 [TBL] [Abstract][Full Text] [Related]
8. Fluoroquinolone use in a rural practice. Kelly L; Schreiber YS; Hopko J; Kirkwood T; Kattini R; Poirier D; Madden S Can J Rural Med; 2021; 26(1):14-18. PubMed ID: 33380601 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of disability in patients exposed to fluoroquinolones. Wilcox MA; Villasis-Keever A; Sena AG; Knoll C; Fife D BMC Pharmacol Toxicol; 2020 Jun; 21(1):40. PubMed ID: 32493505 [TBL] [Abstract][Full Text] [Related]
10. Effects of Fluoroquinolones on Outcomes of Patients With Aortic Dissection or Aneurysm. Chen SW; Chan YH; Chien-Chia Wu V; Cheng YT; Chen DY; Lin CP; Hung KC; Chang SH; Chu PH; Chou AH J Am Coll Cardiol; 2021 Apr; 77(15):1875-1887. PubMed ID: 33858624 [TBL] [Abstract][Full Text] [Related]
11. Risk of aortic aneurysm and dissection following exposure to fluoroquinolones, common antibiotics, and febrile illness using a self-controlled case series study design: Retrospective analyses of three large healthcare databases in the US. Londhe AA; Holy CE; Weaver J; Fonseca S; Villasis A; Fife D PLoS One; 2021; 16(8):e0255887. PubMed ID: 34398907 [TBL] [Abstract][Full Text] [Related]
12. Fluoroquinolone use for uncomplicated urinary tract infections in women: a retrospective cohort study. Daneman N; Chateau D; Dahl M; Zhang J; Fisher A; Sketris IS; Quail J; Marra F; Ernst P; Bugden S; Clin Microbiol Infect; 2020 May; 26(5):613-618. PubMed ID: 31655215 [TBL] [Abstract][Full Text] [Related]
13. Association of Fluoroquinolone Prescribing Rates With Black Box Warnings from the US Food and Drug Administration. Sankar A; Swanson KM; Zhou J; Jena AB; Ross JS; Shah ND; Karaca-Mandic P JAMA Netw Open; 2021 Dec; 4(12):e2136662. PubMed ID: 34851398 [TBL] [Abstract][Full Text] [Related]
14. Lack of association between fluoroquinolone and aortic aneurysm or dissection. Huh K; Kang M; Jung J Eur Heart J; 2023 Nov; 44(42):4476-4484. PubMed ID: 37724037 [TBL] [Abstract][Full Text] [Related]
15. Association Between Aortic Aneurysm and Aortic Dissection With Fluoroquinolones Use in Patients With Urinary Tract Infections: A Population-Based Cohort Study. Chen YY; Yang SF; Yeh HW; Yeh YT; Huang JY; Tsao SL; Yeh CB J Am Heart Assoc; 2022 Mar; 11(6):e023267. PubMed ID: 35229623 [TBL] [Abstract][Full Text] [Related]
16. Alternatives to fluoroquinolones. Med Lett Drugs Ther; 2016 Jun; 58(1496):75-6. PubMed ID: 27249097 [No Abstract] [Full Text] [Related]
17. FDA and the safe and appropriate antibiotic use of fluoroquinolones. Tillotson GS Lancet Infect Dis; 2016 Mar; 16(3):e11-2. PubMed ID: 26973315 [No Abstract] [Full Text] [Related]
18. Indications for Systemic Fluoroquinolone Therapy in Europe and Prevalence of Primary-Care Prescribing in France, Germany and the UK: Descriptive Population-Based Study. Morales DR; Slattery J; Pinheiro L; Kurz X; Hedenmalm K Clin Drug Investig; 2018 Oct; 38(10):927-933. PubMed ID: 30143952 [TBL] [Abstract][Full Text] [Related]
19. Association of Fluoroquinolone Use With Short-term Risk of Development of Aortic Aneurysm. Newton ER; Akerman AW; Strassle PD; Kibbe MR JAMA Surg; 2021 Mar; 156(3):264-272. PubMed ID: 33404647 [TBL] [Abstract][Full Text] [Related]